As sailnyssa astutely observed in another MSB thread, of the last half dozen or so decisions by the FDA, all of treatments with priority review had a a positive FDA decision on or before the relevant decision date.
These is just the facts that sailnyssa put forward. I dont think it necessarily reflects all FDA decisions, but certainly the recent ones.
On that basis, no news by open on Thursday might suggest bad news for MSB.
MSB Trading 2020 - a new dawn, page-5872
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |